Guaifenesin Tablet
Product Images NDC 11673-840

2 FDA label images from Target Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 11673-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

14ct (Ggf)

14ct (Ggf)
Packaging label for up&up Mucus Relief Guaifenesin Extended-Release Tablets 1200 mg. The label highlights the product as maximum strength with 14 extended-release tablets per package. It indicates the tablets relieve chest congestion through thinning and loosening mucus, intended for day or night use with a 12-hour effect. Manufactured for Target Corporation, the label includes a tablet image at actual size and directions, warnings, inactive ingredients, and contact information.*
FDA Label Image

28ct (28ct)

28ct (28ct)
Packaging label for up&up Maximum Strength Mucus Relief Extended-Release Tablets with 1,200 mg guaifenesin. The label highlights the product as an expectorant that relieves chest congestion and thins mucus, for day or night use. The package contains 28 extended-release oral tablets, distributed by Target Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.